Event ~ NHS Medicines Optimisation Conference

AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence. except for the AstraZeneca sponsored symposia presentations.

NHS Medicines Optimisation Conference

“Medicines optimisation is about helping people to get the best outcomes from their medicines. It describes systems and processes used by staff, working in health and social care, which ensure that people receive the best possible care with medicines.” Health Education England

In March 2021 the NHS published the Network Contract Directed Enhanced Service Structured medication reviews and medicines optimisation guidance, this document outlines changes to the delivery of a structured medication review. PCNs must proactively consider all aspects of this guidance when planning, implementing and delivering structured medication reviews (SMR)

SMRs are designed to be a thorough clinical review of a patient’s medicines and detailed aspects of their health. They are delivered by aiding shared decision-making conversations with patients aimed at ensuring that their medication is working well for them.

The Convenzis NHS Medications Optimisation Virtual Conference aims to share key insights and updates following these forward-thinking initiatives and central guidance.

We will explore the “What has worked” and the “What hasn’t” and enable delegates to take part in key Q&A sessions with our panel of guest speakers from across industry and the NHS.

Key Subjects

Over recent years there has been a further focus on the improvement of medicines optimisation across the healthcare ecosystem, other key areas of focus and improvement include:

Improving health outcomes from medicines – Improving patient outcomes through developing patient information, implementing clinically effective prescribing and medicines reviews, and making the best use of the clinical skills of pharmacy teams.
Reducing the overuse of antibiotics – Supporting prescribers in their role in tackling anti-microbial resistance.
Biological and generic medicines – Increasing the use of best value biological and generic medicines, including biosimilar medicines where appropriate, driving millions of pounds worth of savings for reinvesting in NHS treatments,
Decreasing or stopping the use of ineffective medicines – NHS England is working to ensure there is a clear and consistent approach to prescribing across England and to decrease or stop the use of medicines that are not clinically effective or cost-effective.
Implementing the quality and innovation goals – known as a ‘CQUIN’ – for medicines optimisation within specialised services is a priority for secondary care.
Medicines optimisation dashboards: Making it easier for users to develop plans to ensure that all patients achieve the best possible outcomes from their treatment, wherever they live.